Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance upgrade on Thursday 4th of May 2017 from 8.00am to 9.00am (BST).

During this time our websites will be offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 12, 2016
Previous Article Next Article

New potent αvβ3 integrin ligands based on azabicycloalkane (γ,α)-dipeptide mimics

Author affiliations

Abstract

We have designed a new synthetic strategy for the preparation of a new class of cyclic RGD integrin ligands in which the azabicycloalkane scaffold can be envisaged as a (γ,α) dipeptide mimic. The synthesis and in vitro biological evaluation of these RGD derivatives, as well as the computational study of their conformational properties and binding modes to αVβ3 integrin are described. Compound 3 has shown to be a promising candidate as αVβ3 integrin antagonist able to interfere with both cell adhesion and movement on vitronectin with no evidence of cytotoxic effects.

Graphical abstract: New potent αvβ3 integrin ligands based on azabicycloalkane (γ,α)-dipeptide mimics

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 03 Feb 2016, accepted on 19 Feb 2016 and first published on 19 Feb 2016


Article type: Paper
DOI: 10.1039/C6OB00287K
Citation: Org. Biomol. Chem., 2016,14, 3221-3233
  •   Request permissions

    New potent αvβ3 integrin ligands based on azabicycloalkane (γ,α)-dipeptide mimics

    M. Pilkington-Miksa, E. M. V. Araldi, D. Arosio, L. Belvisi, M. Civera and L. Manzoni, Org. Biomol. Chem., 2016, 14, 3221
    DOI: 10.1039/C6OB00287K

Search articles by author